BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1790 related articles for article (PubMed ID: 7037157)

  • 1. Relationship between circulating immune complexes and urinary antigens in human malignancy.
    Huth JF; Gupta RK; Morton DL
    Cancer; 1982 Mar; 49(6):1150-7. PubMed ID: 7037157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of incidence and partial characterization of tumor-associated antigens found in the urine of patients bearing solid tumors.
    Rote NS; Gupta RK; Morton DL
    Int J Cancer; 1980 Aug; 26(2):203-10. PubMed ID: 7009439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an enzyme immunoassay to detect and quantitate tumor-associated antigens in the urine of sarcoma patients.
    Huth JF; Gupta RK; Morton DL
    Cancer; 1981 Jun; 47(12):2856-61. PubMed ID: 7020919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating immune complexes in human malignant melanoma.
    D'Amelio R; Cooke B; Hobbs JR
    Tumori; 1982 Dec; 68(6):469-72. PubMed ID: 7168010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial determinations of melanoma tumor-associated antigen and antibody in patients with stage I melanoma.
    Wong JH; Gupta RK; Morton DL
    Arch Surg; 1986 Nov; 121(11):1342-5. PubMed ID: 3778209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of cancer-associated antigen(s) in urine of sarcoma patients.
    Gupta RK; Morton DL
    J Surg Oncol; 1979; 11(1):65-74. PubMed ID: 285312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous immune complex nephropathy associated with malignancy I. Studies on the nature and immunopathogenic significance of glomerular bound antigen and antibody, isolation and characterization of tumor specific antigen and antibody and circulating immune complexes.
    Ozawa T; Pluss R; Lacher J; Boedecker E; Guggenheim S; Hammond W; McIntosh R
    Q J Med; 1975 Oct; 44(176):523-41. PubMed ID: 53850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic and pathogenetic implications of immune complexes in human cancer.
    Salinas FA; Wee KH
    Adv Immun Cancer Ther; 1986; 2():189-209. PubMed ID: 2962476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and immunochemical characterization of antibodies from the sera of cancer patients which are reactive against human melanoma cell membranes by affinity chromatography.
    Gupta RK; Silver HK; Reisfeld RA; Morton DL
    Cancer Res; 1979 May; 39(5):1683-95. PubMed ID: 427806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery of a cell surface fetal antigen from circulating immune complexes of melanoma patients.
    Wong JH; Aguero B; Gupta RK; Morton DL
    Cancer Immunol Immunother; 1988; 27(2):142-6. PubMed ID: 3046746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-associated antigens detected by autologous sera in urine of patients with solid neoplasms.
    Rote NS; Gupta RK; Morton DL
    J Surg Res; 1980 Jul; 29(1):18-22. PubMed ID: 7421175
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemical classification of circulating immune complexes in human malignant melanoma and hematologic neoplasms.
    Queen WD; Bharwani N; Phillips EA; Ruether BA; Phillips TM; Jerry LM
    Oncology; 1989; 46(1):14-25. PubMed ID: 2915889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Circulating immune complexes in the serum of tumor patients].
    Alvarez R; García Gómez A; Subiza JL; Domínguez J; Bootello A; Coll J
    Rev Esp Oncol; 1982; 29(4):727-34. PubMed ID: 6927370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of urinary antigen analysis by enzyme-linked immunosorbent assay in melanoma patients.
    Gupta RK; Huth JF; Korn EL; Morton DL
    Diagn Immunol; 1983; 1(4):303-9. PubMed ID: 6388975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of tumor-associated antigen in human melanoma cell line supernatants.
    Grimm EA; Silver HK; Roth JA; Chee DO; Gupta RK; Morton DL
    Int J Cancer; 1976 May; 17(5):559-64. PubMed ID: 1270174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating immune complexes in malignant melanoma: serial studies in 130 patients.
    Bharwani N; Campbell L; Ashley P; Queen WD; Phillips TM; Jerry LM
    Oncology; 1986; 43(3):143-8. PubMed ID: 3703459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating immune complexes in patients with bladder cancer and other malignancies of the urogenital tract.
    Kobayashi K; Umeda T; Akaza H; Niijima T; Aikawa T; Tanimoto K
    Urol Int; 1984; 39(4):232-5. PubMed ID: 6485183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of different assays for circulating immune complexes in age matched vasectomized and non-vasectomized men.
    Witkin SS; Brandslund I; Svehag SE; Linnet L; møller NP
    J Clin Lab Immunol; 1983 Apr; 10(4):193-7. PubMed ID: 6602887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of tumor-associated antigens in urine from patients with bladder cancer.
    Gozzo JJ; Cronin WJ; O'Brien P; Monaco AP
    J Urol; 1980 Dec; 124(6):804-7. PubMed ID: 6777508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excretion of tumor-associated antigen(s) in the urine of patients with colon carcinoma.
    Finck SJ; Gupta RK; Giuliano AE; Morton DL
    J Surg Oncol; 1982 Oct; 21(2):81-6. PubMed ID: 7132364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 90.